Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS
· Delayed Price · Currency is USD
0.694
+0.020 (3.03%)
Jun 26, 2026, 4:00 PM EST
Mosaic ImmunoEngineering Employees
As of December 31, 2025, Mosaic ImmunoEngineering had 7 total employees, including 2 full-time and 5 part-time employees. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$136,375
Market Cap
4.88M
Employees Chart
Mosaic ImmunoEngineering News
- 2 years ago - Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc. - Accesswire
- 3 years ago - Mosaic ImmunoEngineering Announces Issuance of U.S. Patent Covering Cancer Treatment with Its Lead Immuno-Oncology Candidate MIE-101 - Accesswire
- 3 years ago - UPDATE: Mosaic ImmunoEngineering's Academic Collaborators Awarded Grants Totaling $4.3 Million from NCI Focused on the Company's Novel Immuno-Oncology Platform - Accesswire
- 3 years ago - Mosaic ImmunoEngineering's Academic Collaborators Awarded Grants Totaling $4.3 Million from NCI Focused on the Company's Novel Immuno-Oncology Plat-form - Accesswire
- 4 years ago - Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University - Accesswire
- 4 years ago - Newly Published Data Further Support Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 in Combination with OX40 Checkpoint Treatment in Melanoma - Accesswire
- 5 years ago - Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 Highlighted in Keynote Presentation - Accesswire
- 5 years ago - Mosaic ImmunoEngineering Announces Upcoming Presentation at the 23rd Annual SoCalBio Conference - Accesswire